<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
83012-052-99
</NDCCode>
<PackageDescription>
1000 mL in 1 BOTTLE (83012-052-99)
</PackageDescription>
<NDC11Code>
83012-0052-99
</NDC11Code>
<ProductNDC>
83012-052
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Aflibercept
</NonProprietaryName>
<DosageFormName>
LIQUID
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20260319
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Boehringer Ingelheim Fremont, Inc.
</LabelerName>
<SubstanceName>
AFLIBERCEPT
</SubstanceName>
<StrengthNumber>
65
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2026-03-21
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
19-MAR-26
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>